Table of Contents Author Guidelines Submit a Manuscript
Developmental Immunology
Volume 7 (2000), Issue 2-4, Pages 239-248
http://dx.doi.org/10.1155/2000/98187

Fibronectin in Immune Responses in Organ Transplant Recipients

1The Dumont-UCLA Transplant Center, Division of Liver and Pancreas Transplantation, Department of Surgery, UCLA School of Medicine, Los Angeles, CA 90095, USA
2The Abel Salazar Institute for Biomedical Sciences, Porto 4000, Portugal
3The Dumont-UCLA Transplant Center, Rm. 77-120 CHS, 10833 Le Conte Ave, Los Angeles, CA 90095, USA

Copyright © 2000 Hindawi Publishing Corporation. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Citations to this Article [14 citations]

The following is the list of published articles that have cited the current article.

  • P Opanasopit, M Hashida, and M Nishikawa, “Factors affecting drug and gene delivery: Effects of interaction with blood components,” Critical Reviews In Therapeutic Drug Carrier Systems, vol. 19, no. 3, pp. 191–233, 2002. View at Publisher · View at Google Scholar
  • Farin Amersi, Xiu-Da Shen, Carolina Moore, Judy Melinek, Ronald W. Busuttil, Jerzy W. Kupiec-Weglinski, and Ana J. Coito, “Fibronectin-α4β1 Integrin-Mediated Blockade Protects Genetically Fat Zucker Rat Livers from Ischemia/Reperfusion Injury,” The American Journal of Pathology, vol. 162, no. 4, pp. 1229–1239, 2003. View at Publisher · View at Google Scholar
  • J Bujan, N Garcia-Honduvilla, and Jm Bellon, “Engineering conduits to resemble natural vascular tissue,” Biotechnology And Applied Biochemistry, vol. 39, pp. 17–27, 2004. View at Publisher · View at Google Scholar
  • C. Moore, X.D. Shen, C. Fondevila, and A.J. Coito, “Fibronectin-α4β1 integrin interactions modulate p42/44 MAPK phosphorylation in steatotic liver cold ischemia-reperfusion injury,” Transplantation Proceedings, vol. 37, no. 1, pp. 432–434, 2005. View at Publisher · View at Google Scholar
  • Carolina Moore, Xiu-Da Shen, Feng Gao, Ronald W. Busuttil, and Ana J. Coito, “Fibronectin-α4β1 Integrin Interactions Regulate Metalloproteinase-9 Expression in Steatotic Liver Ischemia and Reperfusion Injury,” The American Journal of Pathology, vol. 170, no. 2, pp. 567–577, 2007. View at Publisher · View at Google Scholar
  • Guorui Huang, Yue Zhang, Byoungjae Kim, Gaoxiang Ge, Douglas S. Annis, Deane F. Mosher, and Daniel S. Greenspan, “Fibronectin Binds and Enhances the Activity of Bone Morphogenetic Protein 1,” Journal Of Biological Chemistry, vol. 284, no. 38, pp. 25879–25888, 2009. View at Publisher · View at Google Scholar
  • C. Fondevila, X-D Shen, S. Duarte, R. W. Busuttil, and A. J. Coito, “Cytoprotective Effects of a Cyclic RGD Peptide in Steatotic Liver Cold Ischemia and Reperfusion Injury,” American Journal of Transplantation, vol. 9, no. 10, pp. 2240–2250, 2009. View at Publisher · View at Google Scholar
  • Marcus Franz, K. Grün, P. Richter, B. R. Brehm, M. Fritzenwanger, K. Hekmat, D. Neri, J. Gummert, H. R. Figulla, H. Kosmehl, A. Berndt, and A. Renner, “Extra cellular matrix remodelling after heterotopic rat heart transplantation: gene expression profiling and involvement of ED-A+ fibronectin, alpha-smooth muscle actin and B+ tenascin-C in chronic cardiac allograft rejection,” Histochemistry and Cell Biology, vol. 134, no. 5, pp. 503–517, 2010. View at Publisher · View at Google Scholar
  • Ana J Coito, “Leukocyte transmigration across endothelial and extracellular matrix protein barriers in liver ischemia/reperfusion injury,” Current Opinion in Organ Transplantation, vol. 16, no. 1, pp. 34–40, 2011. View at Publisher · View at Google Scholar
  • S. Duarte, X.-D. Shen, C. Fondevila, R. W. Busuttil, and A. J. Coito, “Fibronectin-α4β1 Interactions in Hepatic Cold Ischemia and Reperfusion Injury: Regulation of MMP-9 and MT1-MMP via the p38 MAPK Pathway,” American Journal of Transplantation, vol. 12, no. 10, pp. 2689–2699, 2012. View at Publisher · View at Google Scholar
  • Marcus Franz, Dario Neri, and Alexander Berndt, “ Chronic cardiac allograft rejection: critical role of ED-A + fibronectin and implications for targeted therapy strategies ,” The Journal of Pathology, vol. 226, no. 4, pp. 557–561, 2012. View at Publisher · View at Google Scholar
  • Eric Daugas, Ulrich Blank, Walid Beghdadi, Lydia C. Madjene, Julien Claver, Gunnar Pejler, Lucie Beaudoin, and Agnès Lehuen, “Mast cell chymase protects against renal fibrosis in murine unilateral ureteral obstruction,” Kidney International, 2013. View at Publisher · View at Google Scholar
  • Eva Altrock, Carla Sens, Carina Wuerfel, Matthaeus Vasel, Nina Kawelke, Steven Dooley, Jane Sottile, and Inaam A. Nakchbandi, “Inhibition of fibronectin deposition improves experimental liver fibrosis,” Journal of Hepatology, 2014. View at Publisher · View at Google Scholar
  • Marcus Franz, Monika Matusiak-Brückner, Petra Richter, Katja Grün, Barbara Ziffels, Dario Neri, Hansjörg Maschek, Uwe Schulz, Alexander Pfeil, Christian Jung, Hans R. Figulla, Jan Gummert, Alexander Berndt, and André Renner, “De novo expression of fetal ED-A+ fibronectin and B+ tenascin-C splicing variants in human cardiac allografts: potential impact for targeted therapy of rejection,” Journal of Molecular Histology, 2014. View at Publisher · View at Google Scholar